—James J. Hsieh, MD, PhD, tells us how he thinks the kidney cancer treatment landscape will evolve in coming years. Median survival for patients with metastatic kidney cancer has doubled from 15 ...

Fred Hutchinson Cancer Research Center molecular biologist and oncologist Dr. Andrew Hsieh was elected in the 2022 class of members of the American Society for Clinical Investigation. As a national ...

Dr. Andrew Hsieh of the Human Biology Division is teaming up with colleagues at Fred Hutch and Memorial Sloan Kettering Cancer Center to make progress toward precision medicine for patients with ...

The question used to surprise oncologist Dr. Andrew Hsieh. It would come at the end of a patient’s appointment after he’d reviewed tests, delivered results and laid out treatment options. The patient ...

Though common, bladder cancer has been the focus of relatively little research. Dr. Andrew Hsieh hopes to change that. The physician-scientist at Fred Hutchinson Cancer Research Center is kicking off ...